What is Femara
Approved as Treatment by the FDALetrozole, also known as Femara, is approved by the FDA for 6 uses including HR+, HER2-, Advanced Breast Cancer and Breast .
When to interrupt dosageThe dose of Femara is contingent upon the diagnosed condition, including Polycystic Ovarian Syndrome, Breast and Postmenopause. The magnitude of dosage fluctuates as per the technique of delivery detailed in the table underneath.
Femara Novel Uses: Which Conditions Have a Clinical Trial Featuring Femara?Presently, 74 active studies are being conducted to ascertain the potential of Femara in treating Breast Cancer, Anovulatory cycles and in conjunction with Tamoxifen.
Femara Reviews: What are patients saying about Femara?
Patient Q&A Section about femara
Is Femara successful for fertility?
"Femara can help a woman to conceive approximately 15 percent more each month. Ovulation has been successfully induced in women who were not doing so naturally using Femara. If Femara is used in combination with Intrauterine Insemination (IUI), a woman's chances for pregnancy increase substantially." - Anonymous Online Contributor
What does Femara do for fertility?
"Letrozole is a medication used to lower estrogen production or to induce ovulation in patients with irregular ovulation patterns. It can also help to increase egg production in women who ovulate normally but have unexplained infertility." - Anonymous Online Contributor
What is the medication Femara used for?
"Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer)s.
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers." - Anonymous Online Contributor